Literature DB >> 7743376

Complement activation by the hydroxyl radical during intestinal reperfusion.

R H Turnage1, J C Magee, K S Guice, S I Myers, K T Oldham.   

Abstract

This study examines the hypothesis that hydroxyl radical (OH.) generation during intestinal reperfusion activates the complement system forming the potent chemotaxin C5a. Anesthetized Sprague-Dawley rats underwent 120 min of intestinal ischemia and 60 min of reperfusion (IIR). Complement (C) activation was assessed by measuring total plasma C activity and C5a-related chemotaxis and leukoaggregation. Dimethylthiourea and the iron chelator deferoxamine were utilized to assess the role of the OH. in the activation of C in this model. Sham-operated animals served as controls. Total plasma C activity of animals sustaining IIR was 64% of controls (p < .05). Plasma of animals sustaining IIR induced greater chemotaxis and leukoaggregation than plasma from sham-operated groups (p < .05). Treatment of IIR plasma with anti-C5a antibody ameliorated the enhanced leukoaggregation characteristic of IIR plasma. Pretreatment with dimethylthiorea and deferoxamine prevented reperfusion-induced activation of complement and inhibited the chemotactic activity of plasma from IIR animals. These data are consistent with the hypothesis that IIR activates complement and that the OH. generated during reperfusion may be one mechanism by which C is activated in this injury model.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7743376     DOI: 10.1097/00024382-199412000-00010

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  2 in total

1.  In-vitro activation of complement system by lactic acidosis in newborn and adults.

Authors:  F Hecke; T Hoehn; E Strauss; M Obladen; J Sonntag
Journal:  Mediators Inflamm       Date:  2001-02       Impact factor: 4.711

2.  Acidosis activates complement system in vitro.

Authors:  M Emeis; J Sonntag; C Willam; E Strauss; M M Walka; M Obladen
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.